Alk-Abello A/S (OCSE:ALK B) Accounts Payable : kr134 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Alk-Abello A/S Accounts Payable?

Alk-Abello A/S's Accounts Payable for the quarter that ended in Mar. 2024 was kr134 Mil.

Alk-Abello A/S's quarterly Accounts Payable increased from Sep. 2023 (kr116 Mil) to Dec. 2023 (kr128 Mil) and increased from Dec. 2023 (kr128 Mil) to Mar. 2024 (kr134 Mil).

Alk-Abello A/S's annual Accounts Payable increased from Dec. 2021 (kr115 Mil) to Dec. 2022 (kr131 Mil) but then declined from Dec. 2022 (kr131 Mil) to Dec. 2023 (kr128 Mil).

Alk-Abello A/S Accounts Payable Historical Data

The historical data trend for Alk-Abello A/S's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello A/S Accounts Payable Chart

Alk-Abello A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

81.00

74.00

115.00

131.00

128.00

Alk-Abello A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															125.00	127.00	116.00	128.00	134.00

Alk-Abello A/S Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Alk-Abello A/S Accounts Payable Related Terms

Thank you for viewing the detailed overview of Alk-Abello A/S's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Alk-Abello A/S (OCSE:ALK B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello A/S (OCSE:ALK B) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

AKBLF:USA ALKBc:UK 0OIR:UK 4AJ0:Germany

Address

Boge Alle 6-8, Horsholm, DNK, DK-2970

Website

https://www.alk.net

Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello A/S (OCSE:ALK B) Headlines

No Headlines